» Articles » PMID: 27393617

Characteristics and Prognosis of Interval Cancers After Biennial Screen-film or Full-field Digital Screening Mammography

Overview
Specialty Oncology
Date 2016 Jul 10
PMID 27393617
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We determined the characteristics and prognosis of interval breast cancers (IC) at screen-film (SFM) and full-field digital (FFDM) screening mammography. The study population consisted of 417,746 consecutive screening mammograms (302,699 SFM screens and 115,047 FFDM screens), obtained between 2000 and 2011. During 2-year follow-up, we collected breast imaging reports, surgical reports, and pathology results. A total of 800 ICs had been diagnosed in the screened population, of which 288 detected in the first year (early ICs) and 512 in the second year (late ICs) after a negative screen. 31.3 % of early IC's and 19.1 % of late IC's, respectively, were visible in retrospect on the latest previous screens, but had been missed during screening (P < 0.001). Missed invasive ICs were larger (28.5 mm vs. 23.9 mm, P = 0.003) and showed a higher fraction of T3+cancers (16.9 vs. 8.5 %, P = 0.02) than true ICs (i.e., not visible at the latest screen). A higher portion of missed than true ICs underwent mastectomy (44.7 vs. 30.8 %, P = 0.002). We found no differences in mammographic and tumor characteristics for early ICs, detected either after SFM or FFDM. Late ICs following FFDM were more often true ICs than missed ICs (69.0 vs. 57.6 %, P = 0.03) and more often receptor triple negative (P = 0.02), compared to late ICs at SFM. Interval cancer subgroups showed comparable overall survival. Interval cancer subgroups show distinctive mammographic and tumor characteristics but a comparable overall survival.

Citing Articles

Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.

Nanaa M, Manavaki R, van Nijnatten T, Stranz N, Carriero S, Coleman W Eur Radiol. 2025; .

PMID: 39838090 DOI: 10.1007/s00330-024-11342-x.


Genetic landscape of interval and screen detected breast cancer.

Mills C, Sud A, Everall A, Chubb D, Lawrence S, Kinnersley B NPJ Precis Oncol. 2024; 8(1):122.

PMID: 38806682 PMC: 11133314. DOI: 10.1038/s41698-024-00618-6.


Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.

Song H, Tran T, Kim S, Park B JAMA Netw Open. 2024; 7(5):e2411927.

PMID: 38767918 PMC: 11107304. DOI: 10.1001/jamanetworkopen.2024.11927.


Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.

Nykanen A, Sudah M, Masarwah A, Vanninen R, Okuma H Sci Rep. 2024; 14(1):10001.

PMID: 38693256 PMC: 11063164. DOI: 10.1038/s41598-024-60740-0.


Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme.

Ten Velde D, Duijm L, van der Sangen M, Schipper R, Tjan-Heijnen V, Vreuls W Br J Cancer. 2024; 130(9):1561-1570.

PMID: 38467826 PMC: 11059155. DOI: 10.1038/s41416-024-02633-7.